1. Home
  2. LSTA vs GENK Comparison

LSTA vs GENK Comparison

Compare LSTA & GENK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • GENK
  • Stock Information
  • Founded
  • LSTA 1980
  • GENK 2011
  • Country
  • LSTA United States
  • GENK United States
  • Employees
  • LSTA N/A
  • GENK N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • GENK Restaurants
  • Sector
  • LSTA Health Care
  • GENK Consumer Discretionary
  • Exchange
  • LSTA Nasdaq
  • GENK Nasdaq
  • Market Cap
  • LSTA 22.3M
  • GENK 16.3M
  • IPO Year
  • LSTA N/A
  • GENK 2023
  • Fundamental
  • Price
  • LSTA $2.33
  • GENK $3.17
  • Analyst Decision
  • LSTA Strong Buy
  • GENK Strong Buy
  • Analyst Count
  • LSTA 2
  • GENK 2
  • Target Price
  • LSTA $23.50
  • GENK $7.00
  • AVG Volume (30 Days)
  • LSTA 21.8K
  • GENK 53.8K
  • Earning Date
  • LSTA 11-11-2025
  • GENK 11-11-2025
  • Dividend Yield
  • LSTA N/A
  • GENK 3.90%
  • EPS Growth
  • LSTA N/A
  • GENK N/A
  • EPS
  • LSTA N/A
  • GENK N/A
  • Revenue
  • LSTA $1,070,000.00
  • GENK $216,137,000.00
  • Revenue This Year
  • LSTA N/A
  • GENK $12.35
  • Revenue Next Year
  • LSTA N/A
  • GENK $14.62
  • P/E Ratio
  • LSTA N/A
  • GENK N/A
  • Revenue Growth
  • LSTA N/A
  • GENK 10.67
  • 52 Week Low
  • LSTA $1.87
  • GENK $3.05
  • 52 Week High
  • LSTA $4.20
  • GENK $10.33
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 48.64
  • GENK 43.11
  • Support Level
  • LSTA $2.10
  • GENK $3.11
  • Resistance Level
  • LSTA $2.33
  • GENK $3.39
  • Average True Range (ATR)
  • LSTA 0.17
  • GENK 0.15
  • MACD
  • LSTA 0.01
  • GENK 0.02
  • Stochastic Oscillator
  • LSTA 54.17
  • GENK 38.89

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

About GENK GEN Restaurant Group Inc.

GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. It operates 43 Gen Korean BBQ restaurants in the United States.

Share on Social Networks: